Home
Issues
2022
June 2022 Vol 12, No 3
April 2022 Vol 12, No 2
February 2022 Vol 12, No 1
March 2022 Vol 12 Special Feature
2021
December 2021 Vol 11, No 6
October 2021 Vol 11, No 5
August 2021 Vol 11, No 4
June 2021 Vol 11, No 3
April 2021 Vol 11, No 2
March 2021 Vol 11 Special Feature
February 2021 Vol 11, No 1
2020
December 2020, Vol 10, No 6
October 2020, Vol 10, No 5
August 2020, Vol 10, No 4
June 2020, Vol 10, No 3
April 2020 Vol 10, No 2
February 2020 Vol 10, No 1
Issue Archive
Online First
Special Issues
Supplements
Guide to New FDA Approvals
2021 Year in Review
Multiple Myeloma
Advances in Dual Immunotherapy Cancer Treatments
Renal-Cell Carcinoma
Breast Cancer
Ovarian Cancer
Biosimilars
Non–Small-Cell Lung Cancer
Gastrointestinal Cancer
Categories
Conference Correspondent
ASCO 2022 - Wrap Up
Dual IO 2021 Year in Review
AACR & ASCO 2021 - Midyear Review
ASCO 2021 Breast Cancer Highlights
Web Exclusives
All Web Exclusives
Interview with the Innovators
FDA Approvals
Videos
Press Releases
Lung Cancer Monthly Minutes
Gastrointestinal Cancer Monthly Minutes
Melanoma Monthly Minutes
For Authors
Author Guidelines
Symptom Management Overview
Letters to the Editor Instructions
Peer Review Application
Submit a Manuscript
About
About JHOP
Contact Us
Editorial Policies
Peer-Review Process
About the Editors
Editorial Board
Editorial Process
Advertising Contacts
Advertising Policy
Advertise
Subscribe
Sign Up Now!
To sign up for our newsletter or print publications, please enter your contact information below.
First Name
*
Last Name
*
Email Address
*
Email Address (Verify)
*
JHOP Print Edition
We will request your mailing address on the next page.
JHOP E-Newsletters & Communications
TOP Print Edition
We will request your mailing address on the next page.
TOP E-Newsletters & Communications
I have reviewed and consent to the terms of
JHOP
's
Privacy Policy
, and
JHOP
has my permission to retain my information in its database, and to forward pertinent communications to me.
Home
Issues
2022
June 2022 Vol 12, No 3
April 2022 Vol 12, No 2
February 2022 Vol 12, No 1
March 2022 Vol 12 Special Feature
2021
December 2021 Vol 11, No 6
October 2021 Vol 11, No 5
August 2021 Vol 11, No 4
June 2021 Vol 11, No 3
April 2021 Vol 11, No 2
March 2021 Vol 11 Special Feature
February 2021 Vol 11, No 1
2020
December 2020, Vol 10, No 6
October 2020, Vol 10, No 5
August 2020, Vol 10, No 4
June 2020, Vol 10, No 3
April 2020 Vol 10, No 2
February 2020 Vol 10, No 1
Issue Archive
Online First
Special Issues
Supplements
Guide to New FDA Approvals
2021 Year in Review
Multiple Myeloma
Advances in Dual Immunotherapy Cancer Treatments
Renal-Cell Carcinoma
Breast Cancer
Ovarian Cancer
Biosimilars
Non–Small-Cell Lung Cancer
Gastrointestinal Cancer
Categories
Conference Correspondent
ASCO 2022 - Wrap Up
Dual IO 2021 Year in Review
AACR & ASCO 2021 - Midyear Review
ASCO 2021 Breast Cancer Highlights
Web Exclusives
All Web Exclusives
Interview with the Innovators
FDA Approvals
Videos
Press Releases
Lung Cancer Monthly Minutes
Gastrointestinal Cancer Monthly Minutes
Melanoma Monthly Minutes
For Authors
Author Guidelines
Symptom Management Overview
Letters to the Editor Instructions
Peer Review Application
Submit a Manuscript
About
About JHOP
Contact Us
Editorial Policies
Peer-Review Process
About the Editors
Editorial Board
Editorial Process
Advertising Contacts
Advertising Policy
Advertise
Joseph Bubalo, PharmD, BCPS, BCOP
Authored Items
Ibrutinib-Related Atrial Fibrillation: An Anticoagulant Challenge
Zain Al-Jammali, PharmD
,
Brent Beckner, PharmD
,
Joseph Bubalo, PharmD, BCPS, BCOP
JHOP - June 2019 Vol 9, No 2
in
Symptom Management Overview
Urine Alkalinization and Methotrexate Clearance: Are These Key to Safe Administration of High-Dose Methotrexate?
Joseph Bubalo, PharmD, BCPS, BCOP
JHOP - October 2021 Vol 11, No 5
in
Editorial
Overcoming Resistance: Antibiotic Guidance for Multidrug-Resistant Febrile Neutropenia in Patients with Cancer
Sonya K. Kedzior, PharmD
,
YoungYoon Ham, PharmD
,
Joseph Bubalo, PharmD, BCPS, BCOP
JHOP - April 2021 Vol 11, No 2
in
Review Article
,
Adverse Events
,
Antibiotics
,
Drug Resistance
Direct Oral Anticoagulant Therapy for Heparin-Induced Thrombocytopenia—A New Alternative?
Zain Al-Jammali, PharmD
,
Harleen Singh, PharmD, BCACP
,
Joseph Bubalo, PharmD, BCPS, BCOP
,
Joseph Shatzel, MD
JHOP - June 2020 Vol 10, No 3
in
Symptom Management Overview
,
Oral Anticoagulants
Preventing Chemotherapy-Induced Infertility in Female Patients
Shiela McCollam, PharmD, BCPS
,
Colleen Shipman, PharmD, MPH, BCPS
,
Joseph Bubalo, PharmD, BCPS, BCOP
,
Sacha Krieg, MD, PhD, FACOG
JHOP - December 2019 Vol 9, No 4
in
Symptom Management Overview
Anthracycline-Induced Cardiotoxicity in Adults
Linda Blake, PharmD, PhD, BCPS
,
Alison Palumbo, PharmD, MPH, BCOP
,
Amber Diaz, PharmD, BCOP
,
Joseph Bubalo, PharmD, BCPS, BCOP
JHOP - December 2018 Vol 8, No 4
in
Symptom Management Overview
HER2 Receptor Antagonist–Associated Cardiotoxicity
Alison Palumbo, PharmD, MPH, BCOP
,
Joseph Bubalo, PharmD, BCPS, BCOP
JHOP - Sept 2016 Vol 6, No 3
in
Supportive Care
Hyperuricemia Management
Joseph Bubalo, PharmD, BCPS, BCOP
,
Amber Diaz, PharmD, BCOP
JHOP - June 2015 Vol 5, No 2
in
Supportive Care
Prevention and Treatment of Cytarabine-Induced Keratoconjunctivitis
Joseph Bubalo, PharmD, BCPS, BCOP
JHOP - March 2015 Vol 5, No 1
in
Supportive Care
Pharmacy Practice Opportunities: Is This the Time for Change?
Joseph Bubalo, PharmD, BCPS, BCOP
JHOP - December 2014 VOL 4, NO 4
Hiccups
Joseph Bubalo, PharmD, BCPS, BCOP
JHOP - December 2014 VOL 4, NO 4
in
Supportive Care
Chemotherapy-Induced Peripheral Neuropathy
Joseph Bubalo, PharmD, BCPS, BCOP
JHOP - September 2014 Vol 4, No 3
in
Supportive Care
Last modified: May 3, 2022
Privacy policy
Terms of Use
Home
About
Subscribe
Advertise
Contact Us
Copyright © Green Hill Healthcare Communications, LLC. All rights reserved.
